ESR1 and breast cancer: Conzen et al. highlighted the importance of cancer cell context because they reported that rapamycin-mediated growth inhibition and inactivation of insulin-mediated SGK1 phosphorylation depends on Estrogen receptor alpha (ERα) status in breast cancer cells [86].